Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.Cancer Research|May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)M A Imro, S Manici, V Russo, et al.British Journal of Cancer|July 5, 2006
Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanomaD J Gottlieb, Y-C Li, I Lionello, et al.British Journal of Cancer|July 6, 2013
NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cellsP Di Matteo, C Hackl, C Jedeszko, et al.Human Gene Therapy|November 1, 2001
Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitroG Toietta, G M Severini, C Traversari, et al.Oncogene Research|January 1, 1988
Modulation of the human Harvey-ras oncogene expression by DNA methylationM G Borrello, M A Pierotti, R Donghi, et al.International Journal of Cancer|November 27, 1996
Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3K Fleischhauer, D Fruci, P Van Endert, et al.Human Gene Therapy|June 1, 1995
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantationC Bordignon, C Bonini, S Verzeletti, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1M Sensi, C Traversari, M Radrizzani, et al.Gene Therapy|February 12, 1998
IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancerC Traversari, R Meazza, M Coppolecchia, et al.Pageof 5